[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337543-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337543-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pten-deficiency-potentiates-hbv-associated-liver-cancer-development-through-augmented-gp73golm1","PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1","","Background: Hepatitis B virus (HBV) infection drives hepatic cancer risk, yet most carriers do not develop disease, suggesting additional molecular changes. PTEN is reduced in roughly half of liver cancers, motivating evaluation of PTEN deficiency in HBV-related hepatocarcinogenesis. Methods: PTEN expression was assessed in HBV-positive human liver cancer tissues. Transgenic HBV, Alb-Cre, and Ptenfl/fl mice were inter-crossed, and tumor phenotypes were studied using immunoblotting, histology, and qRT-PCR, including GP73 loss in the combined model. Results: PTEN deletion with HBV transgene synergistically worsened injury, inflammation, fibrosis, and mixed HCC-ICC development, while GP73 increased in HBV;Pten−/− livers. GP73 knockout reduced these synergistic effects. Conclusions: The mixed HCC-ICC model recapitulates HBV patients with PTEN/AKT pathway alterations, supporting GP73 targeting as a therapy strategy for HBV-associated PTEN changes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pten-deficiency-potentiates-hbv-associated-liver-cancer-development-through-augmented-gp73golm1/337543/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pten-deficiency-potentiates-hbv-associated-liver-cancer-development-through-augmented-gp73golm1/337543.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why focus on PTEN deficiency in HBV-related liver cancer development?","Question",{"text":63,"@type":64},"HBV infection is a major liver cancer risk factor, but most carriers do not develop the disease. PTEN is decreased in about half of liver cancers, indicating PTEN deficiency could be an additional molecular alteration driving hepatocarcinogenesis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the PTEN and HBV animal models constructed and analyzed?",{"text":68,"@type":64},"The study used transgenic HBV and Alb-Cre and Ptenfl/fl mice inter-crossed to generate mice with different genetic backgrounds. Liver outcomes were assessed using immunoblotting, histological analysis, and qRT-PCR, and GP73 knockout was tested in a combined model.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does GP73 play in the synergy between PTEN deficiency and HBV?",{"text":72,"@type":64},"GP73 was augmented in HBV;Pten−/− livers. Knocking out GP73 blunted the synergistic effects of PTEN deficiency and HBV transgene on liver injury, inflammation, fibrosis, and cancer development.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337543,1790170841,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Huang et al. Journal of Translational Medicine (2024) 22:254  \n[https://doi.org/10.1186/s12967-024-04976-4](https://doi.org/10.1186/s12967-024-04976-4)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nPTEN deficiency potentiates HBV-associated   liver cancer development through augmented GP73/GOLM1  \nFuqiang Huang1†, Jing Guo1†, Na Zhao1,2†, Mengjie Hou1†, Xiaochen Gai1, Shuhui Yang1, Pei Cai1, Yanan Wang1, Qian Ma3, Qi Zhao1, Li Li1, Huayu Yang6, Yanling Jing1, Di Jin3, Zhongdong Hu4, Xiaojun Zha5, Hongyang Wang7, Yilei Mao6, Fangming Liu1* and Hongbing Zhang1*  \nAbstract  \nBackground Although hepatitis B virus (HBV) infection is a major risk factor for hepatic cancer, the majority of HBV carriers do not develop this lethal disease. Additional molecular alterations are thus implicated in the process of liver tumorigenesis. Since phosphatase and tensin homolog (PTEN) is decreased in approximately half of liver cancers, we investigated the significance of PTEN deficiency in HBV-related hepatocarcinogenesis.  \nMethods HBV-positive human liver cancer tissues were checked for PTEN expression. Transgenic HBV, Alb-Creand Ptenfl/fl mice were inter-crossed to generate WT, HBV, Pten−/− and HBV; Pten−/− mice. Immunoblotting, histological analysis and qRT-PCR were used to study these livers. Gp73−/− mice were then mated with HBV; Pten−/− mice to illustrate the role of hepatic tumor biomarker golgi membrane protein 73 (GP73)/ golgi membrane protein 1 (GOLM1) in hepatic oncogenesis.  \nResults Pten deletion and HBV transgene synergistically aggravated liver injury, inflammation, fibrosis and development of mixed hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) . GP73 was augmented in HBV; Pten−/− livers. Knockout of GP73 blunted the synergistic effect of deficient Pten and transgenic HBV on liver injury, inflammation, fibrosis and cancer development.  \nConclusions This mixed HCC-ICC mouse model mimics liver cancer patients harboring HBV infection and PTEN/AKT signaling pathway alteration. Targeting GP73 is a promising therapeutic strategy for cancer patients with HBV infection and PTEN alteration.  \nKeywords Hepatocellular carcinoma, Intrahepatic cholangiocarcinoma, Hepatitis B virus, Pten, GP73  \n†Fuqiang Huang, Jing Guo, Na Zhao, and Mengjie Hou have contributed equally to this work.  \n*Correspondence:  \nFangming Liu[lfmpumc@163.com](lfmpumc@163.com)[ ](lfmpumc@163.com)Hongbing Zhang [hbzhang@ibms.pumc.edu.cn](hbzhang@ibms.pumc.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativeco](http://creativeco)[mmons.org/publicdomain/zero/1.0/](mmons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nHuang et al. Journal of Translational Medicine (2024) 22:254  \nBackgrou","cbCaikVCWCp9in4m","https://ap.wps.com/l/cbCaikVCWCp9in4m","pdf",2170382,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background","[{\"question\":\"Why focus on PTEN deficiency in HBV-related liver cancer development?\",\"answer\":\"HBV infection is a major liver cancer risk factor, but most carriers do not develop the disease. PTEN is decreased in about half of liver cancers, indicating PTEN deficiency could be an additional molecular alteration driving hepatocarcinogenesis.\"},{\"question\":\"How were the PTEN and HBV animal models constructed and analyzed?\",\"answer\":\"The study used transgenic HBV and Alb-Cre and Ptenfl/fl mice inter-crossed to generate mice with different genetic backgrounds. Liver outcomes were assessed using immunoblotting, histological analysis, and qRT-PCR, and GP73 knockout was tested in a combined model.\"},{\"question\":\"What role does GP73 play in the synergy between PTEN deficiency and HBV?\",\"answer\":\"GP73 was augmented in HBV;Pten−/− livers. Knocking out GP73 blunted the synergistic effects of PTEN deficiency and HBV transgene on liver injury, inflammation, fibrosis, and cancer development.\"}]","PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1 | PDF",1790019570,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd7687641fdeff853d7d46408352b540.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6475aa657bf1526b1cc4bdb8a7133174.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68e8c8ee5cc7254a3163de3dd4ba8ae2.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26c80ff8f564b85fda2bf7cf42d3f547.webp",980,1301]